Complexity in unclassified auto-inflammatory disease: a case report illustrating the potential for disease arising from the allelic burden of multiple variants
Authors:
- Lori B. TuckerLTLori B. Tucker
- Lovro LamotLLLovro Lamot
- Iwona NiemietzINIwona Niemietz
- Brian K. ChungBCBrian K. Chung
- David A. CabralDCDavid A. Cabral
- Kristin HoughtonKHKristin Houghton
- Ross E. PettyRPRoss E. Petty
- Kimberly A. MorishitaKMKimberly A. Morishita
- Gillian I. RiceGRGillian I. Rice
- Stuart E. TurveySTStuart E. Turvey
- William T. GibsonWGWilliam T. Gibson
- Kelly L. BrownKBKelly L. Brown
Open Access
- 28 October 2019
- journal article
- case report
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 17 (1) , 1-7
Abstract
Background: Despite recent advances in the diagnosis and understanding of many autoinflammatory diseases, there are still a great number of patients with phenotypes that do not fit any clinically- and/or genetically-defined disorders. Case presentation: We describe a fourteen-year-old boy who presented at two and a half years of age with recurrent febrile episodes. Over the course of the disease, the episodes increased in frequency and severity, with new signs and symptoms continuing to appear. Most importantly, these included skin changes, splenomegaly and transaminitis. Only partial control of the disease was achieved with anti-IL-1 therapy. Extensive investigation showed generalized inflammation without immune deficiency, with increased levels of serum amyloid A and several pro-inflammatory cytokines including interferon-γ, as well as an increased type I interferon score. Exome sequence analysis identified P369S and R408Q variants in the MEFV innate immunity regulator, pyrin (MEFV) gene and T260 M and T320 M variants in the NLR family pyrin domain containing 12 (NLRP12) gene. Conclusion: Patients with unclassified and/or unexplained autoinflammatory syndromes present diagnostic and therapeutic challenges and collectively form a substantial part of every cohort of patients with autoinflammatory diseases. Therefore, it is important to acquire their full genomic profile through whole exome and/or genome sequencing and present their cases to a broader audience, to facilitate characterization of similar patients. A critical mass of well-characterized cases will lead to improved diagnosis and informed treatment.Keywords
Funding Information
- the Rare Disease Foundation
- The Arthritis Society – Ross Petty Chair in Pediatric Rheumatology start-up fund
- Michael Smith Foundation for Health Research and Cassie & Friends Society Scholar Award
- BC Children’s Hospital Research Institute IGAP award
- Andrew Nord Graduate Student Award in Rheumatology
- Cassie & Friends International Postdoctoral Fellowship
This publication has 19 references indexed in Scilit:
- Periodic fever syndromes: beyond the single gene paradigmPediatric Rheumatology, 2019
- Periodic fever syndromesBest Practice & Research Clinical Rheumatology, 2017
- AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 MutationsCase Reports in Nephrology and Dialysis, 2017
- Diagnosing haemophagocytic syndromeArchives of Disease in Childhood, 2016
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- The Matchmaker Exchange: A Platform for Rare Disease Gene DiscoveryHuman Mutation, 2015
- MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophagesClinical and Experimental Immunology, 2014
- Protracted Febrile Myalgia Syndrome in a Japanese Patient with Fasciitis Detected on MRIInternal Medicine, 2014
- The Risk of Familial Mediterranean Fever in MEFV Heterozygotes: A Statistical ApproachPLOS ONE, 2013
- Pyrin Activates the ASC Pyroptosome in Response to Engagement by Autoinflammatory PSTPIP1 MutantsMolecular Cell, 2007